| Authors: |
Hilmi M; Department of Medical Oncology, Institut Curie, Versailles Saint-Quentin University, Saint-Cloud, France; GERCOR, Paris, France., Khati I; Department of Health Data and Assessment, Health Survey, Data-science and Assessment Division, French National Cancer Institute (INCa), Boulogne Billancourt, France., Turpin A; GERCOR, Paris, France; Department of Medical Oncology, Lille University Hospital, Lille, France., Andremont A; INSERM IAME UMR 1137, Paris, France., Burdet C; Department of Epidemiology, Biostatistics and Clinical Research, Bichat Hospital, AP-HP, Paris, France., Grall N; Microbiology Laboratory, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France., Vidal J; Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medical Oncology, Hospital del Mar, IMIM, CIBERONC, Barcelona, Spain., Bousquet PJ; Department of Health Data and Assessment, Health Survey, Data-science and Assessment Division, French National Cancer Institute (INCa), Boulogne Billancourt, France., Rousseau B; GERCOR, Paris, France; Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: rousseab@mskcc.org., Bihan-Benjamin CL; Department of Health Data and Assessment, Health Survey, Data-science and Assessment Division, French National Cancer Institute (INCa), Boulogne Billancourt, France. |
